Scailyte
Developing artificial intelligence technology for the discovery of complex disease patterns from single-cell data.
Launch date
Employees
Market cap
-
Enterprise valuation
€29—44m (Dealroom.co estimates Dec 2023.)
Company register number CH-100.3.804.016-2
Basel Basel-City (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
N/A | Spinout | ||
* | €2.4m | Seed | |
CHF3.7m | Seed | ||
* | N/A | N/A | Series A |
* | $6.2m | Series A | |
* | N/A | $8.0m | Series A |
| Total Funding | €18.4m | ||
Related Content
Recent News about Scailyte
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.